National Gilles De La Tourette Study Group

NCT00169351 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2005-09-15

No results posted yet for this study

Summary

Tourette syndrome is rare. In France, about 3000 patients have a severe form of the disease. The aim of this study is to collect clinical characteristics in 200 patients with Tourette syndrome.

Conditions

  • Tourette Syndrome

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV
  • Groupe Hospitalier Pitie-Salpetriere

    lead OTHER

Principal Investigators

  • Yves Agid, MD, PhD · Groupe Hospitalier Pitié-Salpêtrière

Eligibility

Min Age
15 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00169351 on ClinicalTrials.gov